Search - tctmd.com

Displaying 461 - 480 of 944

Sort: Relevancy | Date

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

L.A. McKeown

March 22, 2022

News Daily News

Heart Transplant Recipients Fare Poorer When Stroke Is Cause of Death for Younger Donors

Yael L. Maxwell

March 17, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2022

Shelley Wood

February 28, 2022

News Daily News

Skipping Second Dose of mRNA COVID-19 Vaccine May Limit Myocarditis in Adolescents

Todd Neale

February 25, 2022

News Daily News

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

Yael L. Maxwell

February 24, 2022

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

Michael O'Riordan

February 24, 2022

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Shelley Wood

February 22, 2022

News Daily News

Robert M. Califf Becomes 25th Commissioner of the US FDA

L.A. McKeown

February 15, 2022

News Daily News

Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults

L.A. McKeown

February 15, 2022

News Features

Reports of Sudden Deaths Among Athletes After COVID-19 Vax Are ‘Misinformation’

Todd Neale

February 14, 2022

News Daily News

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

L.A. McKeown

February 10, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Opinion Off Script

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

Charles C. Hong, MD, PhD

February 04, 2022

News Conference News STS 2022

Modified Surgical MV Repair Stands Up to Replacement

Michael O'Riordan

February 03, 2022

News Conference News THT 2022

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

L.A. McKeown

February 03, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

Advertisement

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

Heart Transplant Recipients Fare Poorer When Stroke Is Cause of Death for Younger Donors

Guideline-Directed Therapies Underused in Frail HF Patients

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

March 2022 News Roundup

TCTMD’s Top 10 Most Popular Stories for February 2022

Skipping Second Dose of mRNA COVID-19 Vaccine May Limit Myocarditis in Adolescents

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

FDA Approves Empagliflozin for Treatment of HFpEF

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Robert M. Califf Becomes 25th Commissioner of the US FDA

Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults

Reports of Sudden Deaths Among Athletes After COVID-19 Vax Are ‘Misinformation’

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

Modified Surgical MV Repair Stands Up to Replacement

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

February 2022 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content